ヘリオスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/05/08 | 1,775 | 1,826 | 1,755 | 1,816 | +36 | +2% | 113,700 |
2018/05/07 | 1,747 | 1,808 | 1,733 | 1,780 | +69 | +4% | 203,200 |
2018/05/02 | 1,680 | 1,718 | 1,663 | 1,711 | +44 | +2.6% | 109,000 |
2018/05/01 | 1,676 | 1,684 | 1,645 | 1,667 | -7 | -0.4% | 75,800 |
2018/04/27 | 1,628 | 1,678 | 1,616 | 1,674 | +54 | +3.3% | 172,000 |
2018/04/26 | 1,596 | 1,620 | 1,581 | 1,620 | +36 | +2.3% | 73,200 |
2018/04/25 | 1,591 | 1,629 | 1,581 | 1,584 | ±0 | ±0% | 99,500 |
2018/04/24 | 1,564 | 1,594 | 1,564 | 1,584 | +9 | +0.6% | 61,700 |
2018/04/23 | 1,576 | 1,581 | 1,542 | 1,575 | -21 | -1.3% | 121,600 |
2018/04/20 | 1,606 | 1,622 | 1,581 | 1,596 | -18 | -1.1% | 95,800 |
2018/04/19 | 1,648 | 1,654 | 1,602 | 1,614 | -34 | -2.1% | 107,300 |
2018/04/18 | 1,649 | 1,693 | 1,628 | 1,648 | +3 | +0.2% | 91,000 |
2018/04/17 | 1,633 | 1,656 | 1,588 | 1,645 | -28 | -1.7% | 268,000 |
2018/04/16 | 1,700 | 1,700 | 1,606 | 1,673 | +3 | +0.2% | 136,000 |
2018/04/13 | 1,708 | 1,715 | 1,653 | 1,670 | -49 | -2.9% | 162,600 |
2018/04/12 | 1,754 | 1,760 | 1,719 | 1,719 | -35 | -2% | 64,300 |
2018/04/11 | 1,777 | 1,780 | 1,727 | 1,754 | -28 | -1.6% | 88,300 |
2018/04/10 | 1,801 | 1,820 | 1,782 | 1,782 | -41 | -2.2% | 92,100 |
2018/04/09 | 1,803 | 1,854 | 1,777 | 1,823 | -3 | -0.2% | 122,700 |
2018/04/06 | 1,832 | 1,847 | 1,814 | 1,826 | -33 | -1.8% | 93,400 |
2018/04/05 | 1,869 | 1,871 | 1,826 | 1,859 | -1 | -0.1% | 96,700 |
2018/04/04 | 1,945 | 1,958 | 1,859 | 1,860 | -80 | -4.1% | 130,400 |
2018/04/03 | 1,923 | 1,960 | 1,905 | 1,940 | -16 | -0.8% | 64,000 |
2018/04/02 | 1,998 | 2,010 | 1,938 | 1,956 | -34 | -1.7% | 108,400 |
2018/03/30 | 1,976 | 1,990 | 1,944 | 1,990 | +14 | +0.7% | 71,300 |
2018/03/29 | 1,900 | 1,976 | 1,890 | 1,976 | +76 | +4% | 104,200 |
2018/03/28 | 1,886 | 1,918 | 1,871 | 1,900 | +35 | +1.9% | 74,200 |
2018/03/27 | 1,882 | 1,900 | 1,809 | 1,865 | +4 | +0.2% | 129,800 |
2018/03/26 | 1,906 | 1,913 | 1,804 | 1,861 | -67 | -3.5% | 177,400 |
2018/03/23 | 1,970 | 2,008 | 1,928 | 1,928 | -122 | -6% | 153,300 |
2018/03/22 | 1,983 | 2,050 | 1,947 | 2,050 | +72 | +3.6% | 203,300 |
2018/03/20 | 1,922 | 1,983 | 1,911 | 1,978 | -1 | -0.1% | 144,100 |
2018/03/19 | 1,976 | 1,981 | 1,875 | 1,979 | -30 | -1.5% | 128,600 |
2018/03/16 | 2,050 | 2,051 | 1,991 | 2,009 | -40 | -2% | 152,100 |
2018/03/15 | 1,994 | 2,050 | 1,988 | 2,049 | +42 | +2.1% | 195,600 |
2018/03/14 | 1,993 | 2,055 | 1,955 | 2,007 | +45 | +2.3% | 270,700 |
2018/03/13 | 1,973 | 1,973 | 1,927 | 1,962 | +42 | +2.2% | 107,400 |
2018/03/12 | 1,931 | 1,968 | 1,909 | 1,920 | +7 | +0.4% | 98,600 |
2018/03/09 | 1,986 | 1,989 | 1,913 | 1,913 | +26 | +1.4% | 119,900 |
2018/03/08 | 1,859 | 1,890 | 1,840 | 1,887 | +50 | +2.7% | 79,500 |
2018/03/07 | 1,878 | 1,879 | 1,818 | 1,837 | -41 | -2.2% | 92,800 |
2018/03/06 | 1,742 | 1,878 | 1,729 | 1,878 | +176 | +10.3% | 185,100 |
2018/03/05 | 1,780 | 1,785 | 1,686 | 1,702 | -92 | -5.1% | 107,900 |
2018/03/02 | 1,782 | 1,821 | 1,772 | 1,794 | -46 | -2.5% | 109,600 |
2018/03/01 | 1,846 | 1,871 | 1,831 | 1,840 | -23 | -1.2% | 120,800 |
2018/02/28 | 1,876 | 1,910 | 1,860 | 1,863 | -38 | -2% | 185,000 |
2018/02/27 | 1,914 | 1,915 | 1,861 | 1,901 | -28 | -1.5% | 81,200 |
2018/02/26 | 1,896 | 1,930 | 1,888 | 1,929 | +68 | +3.7% | 183,400 |
2018/02/23 | 1,879 | 1,882 | 1,841 | 1,861 | -7 | -0.4% | 90,900 |
2018/02/22 | 1,860 | 1,875 | 1,804 | 1,868 | -1 | -0.1% | 84,400 |
1601~
1650
件表示中 / 2309件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
Chordia | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム